Filter
245
Text search:
NICE
guideline
Featured
Recommendations
34
New Publications
37
Language
Document type
No document type
138
Guidelines
64
Studies & Reports
20
Manuals
9
Fact sheets
7
Training Material
2
Resource Platforms
2
Situation Updates
1
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
India
18
Global
16
Western and Central Europe
8
Russia
7
Ukraine
6
Ecuador
5
Argentina
4
Brazil
4
Germany
3
Kenya
2
South Africa
2
Mozambique
2
Latin America and the Carribbean
2
Africa
2
Eastern Europe
2
Nigeria
1
Guinea-Bissau
1
Ethiopia
1
Cameroon
1
Philippines
1
Namibia
1
Peru
1
Colombia
1
Angola
1
Chile
1
Middle East and North Africa
1
Asia
1
Southern Africa
1
Qatar
1
Estonia
1
Romania
1
Jamaica
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
52
Clinical Guidelines
41
Public Health
22
Women & Child Health
11
Key Resources
4
Pharmacy & Technologies
1
Toolboxes
Mental Health
93
COVID-19
27
NCDs
27
TB
12
Caregiver
8
AMR
6
Disability
5
Conflict
5
Refugee
5
HIV
5
Pharmacy
3
Polio
2
Planetary Health
2
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent
...
Blueprint for EECA countries, first edition
МОДЕЛЬ ПРОТИВОТУБЕРКУЛЕЗНОЙ ПОМОЩИ, ОРИЕНТИРОВАННАЯ НА НУЖДЫ ЛЮДЕЙ
Концептуальный проект модели для стран Восточной Европы и Центрально
...
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
Print version ISSN 1809-9823On-line version ISSN 1981-2256
Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016
http://dx.doi.org/10.1590/1809-98232016019.150040
Developmental disorders
Chapter C.2
2014 Edition
Mood disorders
Chapter E.4
2018 edition
Q8: What is the effectiveness, safety and role of pharmacological interventions, by non-specialized health care providers, for the broad category of Disruptive Behaviour Disorders (DBDs), Conduct Disorder (CD), Oppositional Defiant Disorder (ODD) and comorbid (but not exclusively) Attention-Deficit
...
Developmental disorders
Chapter C.4
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Journal of Child Psychology and Psychiatry60:5 (2019), pp 500–515
Accessed Febr. 6, 2020
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Policy Brief.
Our understanding of how to diagnose and manage Long COVID is still evolving but the condition can be very debilitating. It is associated with a range of overlapping symptoms including generalized chest and muscle pain, fatigue, shortness of breath, and cognitive dysfunction, and the
...
This training module is meant to strengthen the capacity of CHVs to prevent the Non Communicable Diseases at the community level . The Government of Kenya is committed to supporting community health initiatives and accelerating the achievement of the KHSS&IP goals, Millennium Development G
...
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma
...
Klinische Falldefinition einer Post-COVID-19-Erkrankung gemäß Delphi-Konsens, 6.Oktober 2021
recommended
Die WHO hat mit Hilfe der Delphi-Methode eine klinische Falldefinition für das Post-COVID-19-Syndrom entwickelt, die 12 Domänen umfasst und in allen Bereichen verwendet werden kann. Diese erste Version wurde von Patienten, Forschern und anderen Personen aus allen WHO-Regionen entwickelt, wobei dav
...
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs et d'autres personnes, représentant
...
